IBDEI09D ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4316,1,4,0)
 ;;=4^HYPOPHOSPHATEMIA
 ;;^UTILITY(U,$J,358.3,4316,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,4317,0)
 ;;=276.8^^37^422^15
 ;;^UTILITY(U,$J,358.3,4317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4317,1,3,0)
 ;;=3^276.8
 ;;^UTILITY(U,$J,358.3,4317,1,4,0)
 ;;=4^HYPOPOTASSEMIA/HYPOKALEMIA
 ;;^UTILITY(U,$J,358.3,4317,2)
 ;;=^60611
 ;;^UTILITY(U,$J,358.3,4318,0)
 ;;=276.52^^37^422^16
 ;;^UTILITY(U,$J,358.3,4318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4318,1,3,0)
 ;;=3^276.52
 ;;^UTILITY(U,$J,358.3,4318,1,4,0)
 ;;=4^HYPOVOLEMIA
 ;;^UTILITY(U,$J,358.3,4318,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,4319,0)
 ;;=276.4^^37^422^17
 ;;^UTILITY(U,$J,358.3,4319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4319,1,3,0)
 ;;=3^276.4
 ;;^UTILITY(U,$J,358.3,4319,1,4,0)
 ;;=4^MIXED ACID-BASE DISORDER
 ;;^UTILITY(U,$J,358.3,4319,2)
 ;;=^267945
 ;;^UTILITY(U,$J,358.3,4320,0)
 ;;=588.1^^37^422^18
 ;;^UTILITY(U,$J,358.3,4320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4320,1,3,0)
 ;;=3^588.1
 ;;^UTILITY(U,$J,358.3,4320,1,4,0)
 ;;=4^NEPHROGEN DIABETES INSIP
 ;;^UTILITY(U,$J,358.3,4320,2)
 ;;=^276848
 ;;^UTILITY(U,$J,358.3,4321,0)
 ;;=276.50^^37^422^19
 ;;^UTILITY(U,$J,358.3,4321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4321,1,3,0)
 ;;=3^276.50
 ;;^UTILITY(U,$J,358.3,4321,1,4,0)
 ;;=4^VOLUME DEPLETION NOS
 ;;^UTILITY(U,$J,358.3,4321,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,4322,0)
 ;;=275.2^^37^422^7
 ;;^UTILITY(U,$J,358.3,4322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4322,1,3,0)
 ;;=3^275.2
 ;;^UTILITY(U,$J,358.3,4322,1,4,0)
 ;;=4^HYPER/HYPOMAGNESEMIA
 ;;^UTILITY(U,$J,358.3,4322,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,4323,0)
 ;;=584.9^^37^423^1
 ;;^UTILITY(U,$J,358.3,4323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4323,1,3,0)
 ;;=3^584.9
 ;;^UTILITY(U,$J,358.3,4323,1,4,0)
 ;;=4^ACUTE RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,4323,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,4324,0)
 ;;=285.21^^37^423^2
 ;;^UTILITY(U,$J,358.3,4324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4324,1,3,0)
 ;;=3^285.21
 ;;^UTILITY(U,$J,358.3,4324,1,4,0)
 ;;=4^ANEMIA SECONDARY/ESRD
 ;;^UTILITY(U,$J,358.3,4324,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,4325,0)
 ;;=285.29^^37^423^3
 ;;^UTILITY(U,$J,358.3,4325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4325,1,3,0)
 ;;=3^285.29
 ;;^UTILITY(U,$J,358.3,4325,1,4,0)
 ;;=4^ANEMIA SECONDARY/OTH CHR ILLNESS
 ;;^UTILITY(U,$J,358.3,4325,2)
 ;;=^334228
 ;;^UTILITY(U,$J,358.3,4326,0)
 ;;=585.9^^37^423^10
 ;;^UTILITY(U,$J,358.3,4326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4326,1,3,0)
 ;;=3^585.9
 ;;^UTILITY(U,$J,358.3,4326,1,4,0)
 ;;=4^CHRONIC KIDNEY DIS NOS
 ;;^UTILITY(U,$J,358.3,4326,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,4327,0)
 ;;=585.5^^37^423^9
 ;;^UTILITY(U,$J,358.3,4327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4327,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,4327,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,4327,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,4328,0)
 ;;=585.1^^37^423^5
 ;;^UTILITY(U,$J,358.3,4328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4328,1,3,0)
 ;;=3^585.1
 ;;^UTILITY(U,$J,358.3,4328,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,4328,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,4329,0)
 ;;=585.2^^37^423^6
 ;;^UTILITY(U,$J,358.3,4329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4329,1,3,0)
 ;;=3^585.2
 ;;^UTILITY(U,$J,358.3,4329,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,4329,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,4330,0)
 ;;=585.3^^37^423^7
 ;;^UTILITY(U,$J,358.3,4330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4330,1,3,0)
 ;;=3^585.3
